SimpleTrials Expands Feature Set with Contracts and Payments
Oakland, Calif., Aug. 23, 2017 (Business Wire)-Trial By Fire Solutions, a leader in on-demand, web-based clinical trial management solutions that improve planning, execution and tracking of clinical studies, has released SimpleTrials 2.0, a clinical trial management system (CTMS) with new features such as site contracts and payments management. The release also offers updated subscription plans for the SimpleTrials CTMS to meet a greater variety of user needs for teams of all sizes and budgets.
SimpleTrials 2.0 handles complex contract scenarios and payment requirements, providing an effective and streamlined tool. Users can quickly build contract templates applicable to multiple sites. This streamlined contract capability allows effective oversight of international study needs, multiple contract types, and studies with different cohorts and complicated visit schedules. Payment features are seamlessly integrated with subject and visit tracking and include payment history and invoice generation.
-more-
A recent Pharma Tech Outlook article featured the company’s clinical software, which offers full transparency regarding pricing, legal agreements and subscriptions via the SimpleTrials website. Version 2.0 offers updated subscription plans that extend SimpleTrials’ affordability. The premium plan provides access to advanced features, and all plans now allow a greater number of studies.
“SimpleTrials 2.0 offers a low barrier to entry for budget-sensitive teams while delivering the robust functionality demanded by complex studies,” said Nancy Cecchettini, co-founder and chief product officer. “By combining our technology and product management expertise as well as direct clinical trial management experiences, contracts and payments can be managed directly within SimpleTrials, avoiding the need to utilize a separate payment system that can be costly and complicated.”
Sign up for a demo at simpletrials.com.
About SimpleTrials
Trial By Fire Solutions’ SimpleTrials is the first on-demand clinical trial management system (CTMS) in the life science industry. Designed by clinical experts, it is a subscription-based system that supports sponsors, sites, and vendors. Features include management of milestones, startup tracking, documents and eTMF, screening and enrollment, and site visit tracking plus reports and insights from dashboards. For more information, visit simpletrials.com.
About Trial By Fire Solutions
Trial By Fire Solutions is a global leader in web-based clinical trial management solutions and develops innovative applications to improve planning, execution and tracking of clinical studies. Since the release of its SimpleCTMS product, Trial By Fire Solutions has been providing affordable eClinical solutions to teams of all sizes.
CONTACT:
Lea Studer SCORR Marketing 308.237.5567
lea@scorrmarketing.com
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
